Receiving three doses of inactivated or mRNA COVID-19 vaccines was associated with lower odds of long COVID symptoms among people with a history of SARS-CoV-2 infection in Hong Kong, China: a cross-sectional survey study
High prevalence of long COVID symptoms has emerged as a significant public health concern. This study investigated the associations between three doses of COVID-19 vaccines and the presence of any and ≥3 types of long COVID symptoms among people with a history of SARS-CoV-2 infection in Hong Kong, C...
Gespeichert in:
Veröffentlicht in: | Epidemiology and infection 2024-12, Vol.152, p.e166, Article e166 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | e166 |
container_title | Epidemiology and infection |
container_volume | 152 |
creator | Zheng, Chen Yu, Fuk-yuen Chan, Paul Shing-fong Sun, Fenghua Chen, Xiang-Ke Huang, Wendy Ya-Jun Wong, Stephen Heung-Sang Fang, Yuan Wang, Zixin |
description | High prevalence of long COVID symptoms has emerged as a significant public health concern. This study investigated the associations between three doses of COVID-19 vaccines and the presence of any and ≥3 types of long COVID symptoms among people with a history of SARS-CoV-2 infection in Hong Kong, China. This is a secondary analysis of a cross-sectional online survey among Hong Kong adult residents conducted between June and August 2022. This analysis was based on a sub-sample of 1,542 participants with confirmed SARS-CoV-2 infection during the fifth wave of COVID-19 outbreak in Hong Kong (December 2021 to April 2022). Among the participants, 40.9% and 16.1% self-reported having any and ≥3 types of long COVID symptoms, respectively. After adjusting for significant variables related to sociodemographic characteristics, health conditions and lifestyles, and SARS-CoV-2 infection, receiving at least three doses of COVID-19 vaccines was associated with lower odds of reporting any long COVID symptoms comparing to receiving two doses (adjusted odds ratio [AOR]: 0.69, 95% CI: 0.54, 0.87, P = .002). Three doses of inactivated and mRNA vaccines had similar protective effects against long COVID symptoms. It is important to strengthen the coverage of COVID-19 vaccination booster doses, even in the post-pandemic era. |
doi_str_mv | 10.1017/S0950268824001687 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3146628913</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S0950268824001687</cupid><sourcerecordid>3146628913</sourcerecordid><originalsourceid>FETCH-LOGICAL-c298t-dbadebac71383f11d014585cd530321a5d1b69684fb8134cae2edf9ec4337933</originalsourceid><addsrcrecordid>eNp1kctu1DAYhSMEotPCA7BBltiwaMCXXGx2o3BpRUWlmarbyLH_dFwlcbCTGeVdeRiczAASiI1t-f_O8bFOFL0i-B3BJH-_xSLFNOOcJhiTjOdPohVJMhEnCRZPo9U8juf5WXTu_SPGWFCeP4_OmMhSQSlfRT82oMDsTfeAhp0DQNp68MjWyHRSDWYvB9DIOtRuvq1RcXt__TEmAu2lUqYL4EF6JL23yizgwQw71NgDOGS1XnwaG7wXIfJT2w-2DYp2vuzB9g0cNRLtjB-sm2bJdr3ZxoW9j2lIUUOIYbtwQlez6mtYLlGxC_k-BJly1vvYHyHZID-6PUzID6OeXkTPatl4eHnaL6K7z5_uiqv45vbLdbG-iRUVfIh1JTVUUuWEcVYTojFJUp4qnTLMKJGpJlUmMp7UFScsURIo6FqAShjLBWMX0dujbe_s9xH8ULbGK2ga2YEdfclCJxnlgszom7_QRzu6kHuhaM5pKCZQ5Egtn3NQl70zrXRTSXA5N1_-03zQvD45j1UL-rfiV9UBYCdT2VbO6Af48_b_bX8CNX65aw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3142782659</pqid></control><display><type>article</type><title>Receiving three doses of inactivated or mRNA COVID-19 vaccines was associated with lower odds of long COVID symptoms among people with a history of SARS-CoV-2 infection in Hong Kong, China: a cross-sectional survey study</title><source>MEDLINE</source><source>Cambridge Journals Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central</source><creator>Zheng, Chen ; Yu, Fuk-yuen ; Chan, Paul Shing-fong ; Sun, Fenghua ; Chen, Xiang-Ke ; Huang, Wendy Ya-Jun ; Wong, Stephen Heung-Sang ; Fang, Yuan ; Wang, Zixin</creator><creatorcontrib>Zheng, Chen ; Yu, Fuk-yuen ; Chan, Paul Shing-fong ; Sun, Fenghua ; Chen, Xiang-Ke ; Huang, Wendy Ya-Jun ; Wong, Stephen Heung-Sang ; Fang, Yuan ; Wang, Zixin</creatorcontrib><description>High prevalence of long COVID symptoms has emerged as a significant public health concern. This study investigated the associations between three doses of COVID-19 vaccines and the presence of any and ≥3 types of long COVID symptoms among people with a history of SARS-CoV-2 infection in Hong Kong, China. This is a secondary analysis of a cross-sectional online survey among Hong Kong adult residents conducted between June and August 2022. This analysis was based on a sub-sample of 1,542 participants with confirmed SARS-CoV-2 infection during the fifth wave of COVID-19 outbreak in Hong Kong (December 2021 to April 2022). Among the participants, 40.9% and 16.1% self-reported having any and ≥3 types of long COVID symptoms, respectively. After adjusting for significant variables related to sociodemographic characteristics, health conditions and lifestyles, and SARS-CoV-2 infection, receiving at least three doses of COVID-19 vaccines was associated with lower odds of reporting any long COVID symptoms comparing to receiving two doses (adjusted odds ratio [AOR]: 0.69, 95% CI: 0.54, 0.87, P = .002). Three doses of inactivated and mRNA vaccines had similar protective effects against long COVID symptoms. It is important to strengthen the coverage of COVID-19 vaccination booster doses, even in the post-pandemic era.</description><identifier>ISSN: 0950-2688</identifier><identifier>ISSN: 1469-4409</identifier><identifier>EISSN: 1469-4409</identifier><identifier>DOI: 10.1017/S0950268824001687</identifier><identifier>PMID: 39659228</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Adolescent ; Adult ; Aged ; Bacterial infections ; Chronic illnesses ; COVID-19 ; COVID-19 - epidemiology ; COVID-19 - prevention & control ; COVID-19 vaccines ; COVID-19 Vaccines - administration & dosage ; Cross-Sectional Studies ; Deactivation ; Female ; Health surveys ; Hong Kong - epidemiology ; Hospitalization ; Humans ; Investigations ; Lifestyles ; Long COVID ; Male ; Mental disorders ; Mental health ; Middle Aged ; mRNA ; mRNA Vaccines ; Original Paper ; Pandemics ; Public health ; SARS-CoV-2 - immunology ; Secondary analysis ; Sedentary behavior ; Self report ; Severe acute respiratory syndrome coronavirus 2 ; Vaccines ; Vaccines, Inactivated - administration & dosage ; Vectors (Biology) ; Viral diseases ; Young Adult</subject><ispartof>Epidemiology and infection, 2024-12, Vol.152, p.e166, Article e166</ispartof><rights>The Author(s), 2024. Published by Cambridge University Press</rights><rights>The Author(s), 2024. Published by Cambridge University Press. This work is licensed under the Creative Commons Attribution License This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c298t-dbadebac71383f11d014585cd530321a5d1b69684fb8134cae2edf9ec4337933</cites><orcidid>0000-0002-1158-2304</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S0950268824001687/type/journal_article$$EHTML$$P50$$Gcambridge$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,864,23318,27924,27925,55804</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39659228$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zheng, Chen</creatorcontrib><creatorcontrib>Yu, Fuk-yuen</creatorcontrib><creatorcontrib>Chan, Paul Shing-fong</creatorcontrib><creatorcontrib>Sun, Fenghua</creatorcontrib><creatorcontrib>Chen, Xiang-Ke</creatorcontrib><creatorcontrib>Huang, Wendy Ya-Jun</creatorcontrib><creatorcontrib>Wong, Stephen Heung-Sang</creatorcontrib><creatorcontrib>Fang, Yuan</creatorcontrib><creatorcontrib>Wang, Zixin</creatorcontrib><title>Receiving three doses of inactivated or mRNA COVID-19 vaccines was associated with lower odds of long COVID symptoms among people with a history of SARS-CoV-2 infection in Hong Kong, China: a cross-sectional survey study</title><title>Epidemiology and infection</title><addtitle>Epidemiol. Infect</addtitle><description>High prevalence of long COVID symptoms has emerged as a significant public health concern. This study investigated the associations between three doses of COVID-19 vaccines and the presence of any and ≥3 types of long COVID symptoms among people with a history of SARS-CoV-2 infection in Hong Kong, China. This is a secondary analysis of a cross-sectional online survey among Hong Kong adult residents conducted between June and August 2022. This analysis was based on a sub-sample of 1,542 participants with confirmed SARS-CoV-2 infection during the fifth wave of COVID-19 outbreak in Hong Kong (December 2021 to April 2022). Among the participants, 40.9% and 16.1% self-reported having any and ≥3 types of long COVID symptoms, respectively. After adjusting for significant variables related to sociodemographic characteristics, health conditions and lifestyles, and SARS-CoV-2 infection, receiving at least three doses of COVID-19 vaccines was associated with lower odds of reporting any long COVID symptoms comparing to receiving two doses (adjusted odds ratio [AOR]: 0.69, 95% CI: 0.54, 0.87, P = .002). Three doses of inactivated and mRNA vaccines had similar protective effects against long COVID symptoms. It is important to strengthen the coverage of COVID-19 vaccination booster doses, even in the post-pandemic era.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Bacterial infections</subject><subject>Chronic illnesses</subject><subject>COVID-19</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 - prevention & control</subject><subject>COVID-19 vaccines</subject><subject>COVID-19 Vaccines - administration & dosage</subject><subject>Cross-Sectional Studies</subject><subject>Deactivation</subject><subject>Female</subject><subject>Health surveys</subject><subject>Hong Kong - epidemiology</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Investigations</subject><subject>Lifestyles</subject><subject>Long COVID</subject><subject>Male</subject><subject>Mental disorders</subject><subject>Mental health</subject><subject>Middle Aged</subject><subject>mRNA</subject><subject>mRNA Vaccines</subject><subject>Original Paper</subject><subject>Pandemics</subject><subject>Public health</subject><subject>SARS-CoV-2 - immunology</subject><subject>Secondary analysis</subject><subject>Sedentary behavior</subject><subject>Self report</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Vaccines</subject><subject>Vaccines, Inactivated - administration & dosage</subject><subject>Vectors (Biology)</subject><subject>Viral diseases</subject><subject>Young Adult</subject><issn>0950-2688</issn><issn>1469-4409</issn><issn>1469-4409</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>IKXGN</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kctu1DAYhSMEotPCA7BBltiwaMCXXGx2o3BpRUWlmarbyLH_dFwlcbCTGeVdeRiczAASiI1t-f_O8bFOFL0i-B3BJH-_xSLFNOOcJhiTjOdPohVJMhEnCRZPo9U8juf5WXTu_SPGWFCeP4_OmMhSQSlfRT82oMDsTfeAhp0DQNp68MjWyHRSDWYvB9DIOtRuvq1RcXt__TEmAu2lUqYL4EF6JL23yizgwQw71NgDOGS1XnwaG7wXIfJT2w-2DYp2vuzB9g0cNRLtjB-sm2bJdr3ZxoW9j2lIUUOIYbtwQlez6mtYLlGxC_k-BJly1vvYHyHZID-6PUzID6OeXkTPatl4eHnaL6K7z5_uiqv45vbLdbG-iRUVfIh1JTVUUuWEcVYTojFJUp4qnTLMKJGpJlUmMp7UFScsURIo6FqAShjLBWMX0dujbe_s9xH8ULbGK2ga2YEdfclCJxnlgszom7_QRzu6kHuhaM5pKCZQ5Egtn3NQl70zrXRTSXA5N1_-03zQvD45j1UL-rfiV9UBYCdT2VbO6Af48_b_bX8CNX65aw</recordid><startdate>20241211</startdate><enddate>20241211</enddate><creator>Zheng, Chen</creator><creator>Yu, Fuk-yuen</creator><creator>Chan, Paul Shing-fong</creator><creator>Sun, Fenghua</creator><creator>Chen, Xiang-Ke</creator><creator>Huang, Wendy Ya-Jun</creator><creator>Wong, Stephen Heung-Sang</creator><creator>Fang, Yuan</creator><creator>Wang, Zixin</creator><general>Cambridge University Press</general><scope>IKXGN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1158-2304</orcidid></search><sort><creationdate>20241211</creationdate><title>Receiving three doses of inactivated or mRNA COVID-19 vaccines was associated with lower odds of long COVID symptoms among people with a history of SARS-CoV-2 infection in Hong Kong, China: a cross-sectional survey study</title><author>Zheng, Chen ; Yu, Fuk-yuen ; Chan, Paul Shing-fong ; Sun, Fenghua ; Chen, Xiang-Ke ; Huang, Wendy Ya-Jun ; Wong, Stephen Heung-Sang ; Fang, Yuan ; Wang, Zixin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c298t-dbadebac71383f11d014585cd530321a5d1b69684fb8134cae2edf9ec4337933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Bacterial infections</topic><topic>Chronic illnesses</topic><topic>COVID-19</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 - prevention & control</topic><topic>COVID-19 vaccines</topic><topic>COVID-19 Vaccines - administration & dosage</topic><topic>Cross-Sectional Studies</topic><topic>Deactivation</topic><topic>Female</topic><topic>Health surveys</topic><topic>Hong Kong - epidemiology</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Investigations</topic><topic>Lifestyles</topic><topic>Long COVID</topic><topic>Male</topic><topic>Mental disorders</topic><topic>Mental health</topic><topic>Middle Aged</topic><topic>mRNA</topic><topic>mRNA Vaccines</topic><topic>Original Paper</topic><topic>Pandemics</topic><topic>Public health</topic><topic>SARS-CoV-2 - immunology</topic><topic>Secondary analysis</topic><topic>Sedentary behavior</topic><topic>Self report</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Vaccines</topic><topic>Vaccines, Inactivated - administration & dosage</topic><topic>Vectors (Biology)</topic><topic>Viral diseases</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zheng, Chen</creatorcontrib><creatorcontrib>Yu, Fuk-yuen</creatorcontrib><creatorcontrib>Chan, Paul Shing-fong</creatorcontrib><creatorcontrib>Sun, Fenghua</creatorcontrib><creatorcontrib>Chen, Xiang-Ke</creatorcontrib><creatorcontrib>Huang, Wendy Ya-Jun</creatorcontrib><creatorcontrib>Wong, Stephen Heung-Sang</creatorcontrib><creatorcontrib>Fang, Yuan</creatorcontrib><creatorcontrib>Wang, Zixin</creatorcontrib><collection>Cambridge Journals Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Epidemiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zheng, Chen</au><au>Yu, Fuk-yuen</au><au>Chan, Paul Shing-fong</au><au>Sun, Fenghua</au><au>Chen, Xiang-Ke</au><au>Huang, Wendy Ya-Jun</au><au>Wong, Stephen Heung-Sang</au><au>Fang, Yuan</au><au>Wang, Zixin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Receiving three doses of inactivated or mRNA COVID-19 vaccines was associated with lower odds of long COVID symptoms among people with a history of SARS-CoV-2 infection in Hong Kong, China: a cross-sectional survey study</atitle><jtitle>Epidemiology and infection</jtitle><addtitle>Epidemiol. Infect</addtitle><date>2024-12-11</date><risdate>2024</risdate><volume>152</volume><spage>e166</spage><pages>e166-</pages><artnum>e166</artnum><issn>0950-2688</issn><issn>1469-4409</issn><eissn>1469-4409</eissn><abstract>High prevalence of long COVID symptoms has emerged as a significant public health concern. This study investigated the associations between three doses of COVID-19 vaccines and the presence of any and ≥3 types of long COVID symptoms among people with a history of SARS-CoV-2 infection in Hong Kong, China. This is a secondary analysis of a cross-sectional online survey among Hong Kong adult residents conducted between June and August 2022. This analysis was based on a sub-sample of 1,542 participants with confirmed SARS-CoV-2 infection during the fifth wave of COVID-19 outbreak in Hong Kong (December 2021 to April 2022). Among the participants, 40.9% and 16.1% self-reported having any and ≥3 types of long COVID symptoms, respectively. After adjusting for significant variables related to sociodemographic characteristics, health conditions and lifestyles, and SARS-CoV-2 infection, receiving at least three doses of COVID-19 vaccines was associated with lower odds of reporting any long COVID symptoms comparing to receiving two doses (adjusted odds ratio [AOR]: 0.69, 95% CI: 0.54, 0.87, P = .002). Three doses of inactivated and mRNA vaccines had similar protective effects against long COVID symptoms. It is important to strengthen the coverage of COVID-19 vaccination booster doses, even in the post-pandemic era.</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><pmid>39659228</pmid><doi>10.1017/S0950268824001687</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-1158-2304</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0950-2688 |
ispartof | Epidemiology and infection, 2024-12, Vol.152, p.e166, Article e166 |
issn | 0950-2688 1469-4409 1469-4409 |
language | eng |
recordid | cdi_proquest_miscellaneous_3146628913 |
source | MEDLINE; Cambridge Journals Open Access; DOAJ Directory of Open Access Journals; PubMed Central |
subjects | Adolescent Adult Aged Bacterial infections Chronic illnesses COVID-19 COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - administration & dosage Cross-Sectional Studies Deactivation Female Health surveys Hong Kong - epidemiology Hospitalization Humans Investigations Lifestyles Long COVID Male Mental disorders Mental health Middle Aged mRNA mRNA Vaccines Original Paper Pandemics Public health SARS-CoV-2 - immunology Secondary analysis Sedentary behavior Self report Severe acute respiratory syndrome coronavirus 2 Vaccines Vaccines, Inactivated - administration & dosage Vectors (Biology) Viral diseases Young Adult |
title | Receiving three doses of inactivated or mRNA COVID-19 vaccines was associated with lower odds of long COVID symptoms among people with a history of SARS-CoV-2 infection in Hong Kong, China: a cross-sectional survey study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T22%3A07%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Receiving%20three%20doses%20of%20inactivated%20or%20mRNA%20COVID-19%20vaccines%20was%20associated%20with%20lower%20odds%20of%20long%20COVID%20symptoms%20among%20people%20with%20a%20history%20of%20SARS-CoV-2%20infection%20in%20Hong%20Kong,%20China:%20a%20cross-sectional%20survey%20study&rft.jtitle=Epidemiology%20and%20infection&rft.au=Zheng,%20Chen&rft.date=2024-12-11&rft.volume=152&rft.spage=e166&rft.pages=e166-&rft.artnum=e166&rft.issn=0950-2688&rft.eissn=1469-4409&rft_id=info:doi/10.1017/S0950268824001687&rft_dat=%3Cproquest_cross%3E3146628913%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3142782659&rft_id=info:pmid/39659228&rft_cupid=10_1017_S0950268824001687&rfr_iscdi=true |